BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 2080684)

  • 1. [New knowledge on the diagnosis and prognosis of interstitial lung disease in scleroderma].
    König G; Behr J; Luderschmidt C
    Z Rheumatol; 1990; 49(5):279-83. PubMed ID: 2080684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pulmonary involvement in sclerodermia].
    Paone G; Di Michele L; Mattia P; Tonnarini R; Lucifora V; Fiorucci F
    Minerva Med; 1994 Jun; 85(6):293-300. PubMed ID: 8084431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bronchoalveolar lavage cellular profiles in patients with systemic sclerosis-associated interstitial lung disease are not predictive of disease progression.
    Goh NS; Veeraraghavan S; Desai SR; Cramer D; Hansell DM; Denton CP; Black CM; du Bois RM; Wells AU
    Arthritis Rheum; 2007 Jun; 56(6):2005-12. PubMed ID: 17530640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relation between 67-gallium scintigraphy and bronchoalveolar lavage--differential cell count and superoxide anion liberation--in patients with systemic scleroderma and systemic lupus erythematosus].
    Witt C; Apostoloff E; Müller GM; Buchali K; Hiepe F; Brenke A; Romberg B; Winsel K
    Pneumologie; 1992 Jan; 46(1):20-5. PubMed ID: 1312240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of type 2 cytokines by CD8+ lung cells is associated with greater decline in pulmonary function in patients with systemic sclerosis.
    Atamas SP; Yurovsky VV; Wise R; Wigley FM; Goter Robinson CJ; Henry P; Alms WJ; White B
    Arthritis Rheum; 1999 Jun; 42(6):1168-78. PubMed ID: 10366109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induced sputum as a tool for early detection of airway inflammation in connective diseases-related lung involvement.
    Vatrella A; Bocchino M; Perna F; Scarpa R; Galati D; Spina S; Pelaia G; Cazzola M; Sanduzzi A
    Respir Med; 2007 Jul; 101(7):1383-9. PubMed ID: 17369033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The presence of Sjögren's syndrome is a major determinant of the pattern of interstitial lung disease in scleroderma and other connective tissue diseases.
    Breit SN; Cairns D; Szentirmay A; Callaghan T; Murray D; Wacher T; Gibson PG; Marks G; Bryant DH; Yeates M
    J Rheumatol; 1989 Aug; 16(8):1043-9. PubMed ID: 2585401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mast cells in bronchoalveolar lavage fluid of patients with interstitial lung diseases].
    Schildge J; Klar B; Hardung-Backes M
    Pneumologie; 2003 Apr; 57(4):202-7. PubMed ID: 12690558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemiluminescence measurements of bronchoalveolar lavage cells in patients with collagenosis].
    Witt C; Winsel K; Apostoloff E; Brenke A; Hiepe F; Renner H
    Z Erkr Atmungsorgane; 1990; 175(2):81-7. PubMed ID: 2264364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study.
    Khanna D; Clements PJ; Furst DE; Chon Y; Elashoff R; Roth MD; Sterz MG; Chung J; FitzGerald JD; Seibold JR; Varga J; Theodore A; Wigley FM; Silver RM; Steen VD; Mayes MD; Connolly MK; Fessler BJ; Rothfield NF; Mubarak K; Molitor J; Tashkin DP;
    Arthritis Rheum; 2005 Feb; 52(2):592-600. PubMed ID: 15692967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of inflammation in the lung disease of systemic sclerosis: comparison with idiopathic pulmonary fibrosis.
    Owens GR; Paradis IL; Gryzan S; Medsger TA; Follansbee WP; Klein HA; Dauber JH
    J Lab Clin Med; 1986 Mar; 107(3):253-60. PubMed ID: 3950467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical value of bronchoalveolar lavage in progressive systemic scleroderma (author's transl)].
    König G; Luderschmidt C; Clocuh YP; Scherer U; Fruhmann G
    Dtsch Med Wochenschr; 1982 May; 107(19):723-7. PubMed ID: 7075490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCL18 as an indicator of pulmonary fibrotic activity in idiopathic interstitial pneumonias and systemic sclerosis.
    Prasse A; Pechkovsky DV; Toews GB; Schäfer M; Eggeling S; Ludwig C; Germann M; Kollert F; Zissel G; Müller-Quernheim J
    Arthritis Rheum; 2007 May; 56(5):1685-93. PubMed ID: 17469163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence of abnormal bronchoalveolar lavage findings after cyclophosphamide treatment in scleroderma patients with interstitial lung disease.
    Mittoo S; Wigley FM; Wise R; Xiao H; Hummers L
    Arthritis Rheum; 2007 Dec; 56(12):4195-202. PubMed ID: 18050251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correlation between bronchoalveolar lavage and lung function in patients with systemic sclerosis and rheumatoid arthritis].
    Pejcić T; Stanković I; Rancić M; Djordjević I; Ristić L; Vojinović J
    Srp Arh Celok Lek; 2005 Dec; 133 Suppl 2():129-33. PubMed ID: 16535997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical aspects of progressive systemic scleroderma (PSS). Multicenter studies of 194 patients].
    Goerz G; Hammer G; Wirth G; Hornstein OP; Keller GJ; Altmeyer P; Holzmann H; Meigel W; Mensing H; Braun-Falco O
    Hautarzt; 1986 Jun; 37(6):320-4. PubMed ID: 3522484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung disease associated with progressive systemic sclerosis. Assessment of interlobar variation by bronchoalveolar lavage and comparison with noninvasive evaluation of disease activity.
    Miller KS; Smith EA; Kinsella M; Schabel SI; Silver RM
    Am Rev Respir Dis; 1990 Feb; 141(2):301-6. PubMed ID: 2301848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induced sputum in systemic sclerosis interstitial lung disease: comparison to healthy controls and bronchoalveolar lavage.
    Damjanov N; Ostojic P; Kaloudi O; Alari S; Guiducci S; Stanflin N; Nestorovic B; Knezevic J; Camiciottoli G; Porta F; Pistolesi M; Ibba-Manneschi L; Conforti ML; Candelieri A; Matucci Cerinic M
    Respiration; 2009; 78(1):56-62. PubMed ID: 18931474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated levels of platelet derived growth factor and transforming growth factor-beta 1 in bronchoalveolar lavage fluid from patients with scleroderma.
    Ludwicka A; Ohba T; Trojanowska M; Yamakage A; Strange C; Smith EA; Leroy EC; Sutherland S; Silver RM
    J Rheumatol; 1995 Oct; 22(10):1876-83. PubMed ID: 8991985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung involvement in scleroderma.
    König G; Luderschmidt C; Hammer C; Adelmann-Grill BC; Braun-Falco O; Fruhmann G
    Chest; 1984 Mar; 85(3):318-24. PubMed ID: 6321113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.